These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 11878194

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Preclinical safety and pharmacology of an anti-human interleukin-13 monoclonal antibody in normal macaques and in macaques with allergic asthma.
    Martin PL, Fisher D, Glass W, O'Neil K, Das A, Martin EC, Li L.
    Int J Toxicol; 2008; 27(5):351-8. PubMed ID: 19037805
    [Abstract] [Full Text] [Related]

  • 24. Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma.
    Noga O, Hanf G, Brachmann I, Klucken AC, Kleine-Tebbe J, Rosseau S, Kunkel G, Suttorp N, Seybold J.
    J Allergy Clin Immunol; 2006 Jun; 117(6):1493-9. PubMed ID: 16751018
    [Abstract] [Full Text] [Related]

  • 25. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L, Sorkness CA.
    Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
    [Abstract] [Full Text] [Related]

  • 26. Immunomodulation in asthma: a distant dream or a close reality?
    Bharadwaj A, Agrawal DK.
    Int Immunopharmacol; 2004 Apr; 4(4):495-511. PubMed ID: 15099527
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma.
    Chung KF.
    Sci STKE; 2005 Sep 27; 2005(303):pe47. PubMed ID: 16189372
    [Abstract] [Full Text] [Related]

  • 28. Anti-IgE in severe persistent allergic asthma.
    Fox H.
    Respirology; 2007 Nov 27; 12 Suppl 3():S22-8; discussion S45-7. PubMed ID: 17956516
    [Abstract] [Full Text] [Related]

  • 29. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A, Sternon J.
    J Pharm Belg; 2006 Nov 27; 61(3):83-7. PubMed ID: 17058881
    [Abstract] [Full Text] [Related]

  • 30. Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists.
    Currie GP, Srivastava P, Dempsey OJ, Lee DK.
    QJM; 2005 Mar 27; 98(3):171-82. PubMed ID: 15728398
    [Abstract] [Full Text] [Related]

  • 31. [Future perspectives in the therapy of asthma in children].
    Tosca MA, Villa E, Rossi GA.
    Minerva Pediatr; 2008 Apr 27; 60(2):235-47. PubMed ID: 18449140
    [Abstract] [Full Text] [Related]

  • 32. Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with beta2-adrenergic agonists.
    Goleva E, Dunlap A, Leung DY.
    J Allergy Clin Immunol; 2004 Jul 27; 114(1):183-91. PubMed ID: 15241363
    [Abstract] [Full Text] [Related]

  • 33. Targeting airway inflammation: novel therapies for the treatment of asthma.
    Walsh GM.
    Curr Med Chem; 2006 Jul 27; 13(25):3105-11. PubMed ID: 17073650
    [Abstract] [Full Text] [Related]

  • 34. [New treatments for bronchial asthma].
    Frezet MM, Braida A, Dore M, Gani F.
    Recenti Prog Med; 2004 Jun 27; 95(6):289-96. PubMed ID: 15248410
    [Abstract] [Full Text] [Related]

  • 35. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE.
    Pharmacol Ther; 2007 Jan 27; 113(1):121-33. PubMed ID: 17000005
    [Abstract] [Full Text] [Related]

  • 36. Use of CpG oligonucleotides in treatment of asthma and allergic disease.
    Fonseca DE, Kline JN.
    Adv Drug Deliv Rev; 2009 Mar 28; 61(3):256-62. PubMed ID: 19167442
    [Abstract] [Full Text] [Related]

  • 37. Methods used in clinical development of novel anti-asthma therapies.
    Diamant Z, Boot D, Kamerling I, Bjermer L.
    Respir Med; 2008 Mar 28; 102(3):332-8. PubMed ID: 18061420
    [Abstract] [Full Text] [Related]

  • 38. Newer therapies for asthma: a focus on anti-IgE.
    Babu KS, Holgate ST.
    Indian J Chest Dis Allied Sci; 2002 Mar 28; 44(2):107-15. PubMed ID: 12026249
    [Abstract] [Full Text] [Related]

  • 39. Omalizumab in the treatment of severe asthma: efficacy and current problems.
    Pelaia G, Renda T, Romeo P, Busceti MT, Maselli R.
    Ther Adv Respir Dis; 2008 Dec 28; 2(6):409-21. PubMed ID: 19124386
    [Abstract] [Full Text] [Related]

  • 40. [Immunomodulation therapy for allergic asthma. What is already possible, what is to come?].
    Taube C, Buhl R.
    Dtsch Med Wochenschr; 2008 Apr 28; 133(14):727-32. PubMed ID: 18363195
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.